NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx
NewsRx | Free Newsletters
NewsRx | Free Trials
VerticalNews | Global Warming
Encyk AD
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bronchiolitis Obliterans



Bronchiolitis obliterans can limit survival after lung transplantation



September 9th, 2004

Although bronchiolitis obliterans negatively affects quality of life, some patients may still benefit from lung transplantation.

According to recent research published in the journal Clinical Transplantation, "Bronchiolitis obliterans syndrome (BOS) is the most important factor limiting long-term survival after lung transplantation, and has a substantial impact on patients' daily life in terms of disability and morbidity."

"The aim of our study was to examine the effects of BOS on health related quality of life (HRQL) in lung transplantation patients. Data on HRQL from 29 patients who developed BOS at least 18 months earlier were...


Source: Blood Weekly (2004-09-09)

NewsRx Passes
More Articles

------------------------
Security by Verisign PR Login